🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

2,762 results for “CTI” Clear

  1. Chemoembolization and Response-Dependent Resection

    The First People's Hospital of Lianyungang

    Resectable Hepatocellular Carcinoma Beyond Milan Criteria

    approved other active

    1 trial

  2. Chlorhexidine

    CRESCENT BIOPHARMA, INC.

    Neonatal Infections

    approved small molecule completed

    1 trial

  3. Cilostazol

    Otsuka Beijing Research Institute

    Cerebral Infarction

    approved small molecule completed

    1 trial

  4. Cinobufacini injection

    The First People's Hospital of Lianyungang

    Liver Cancer

    approved small molecule active

    1 trial

  5. Ciprofloxacin

    Iterum Therapeutics plc

    UTI - Lower Urinary Tract Infection

    approved small molecule completed

    1 trial

  6. Clensia polvo para solución oral., CitraFleet Polvo para solución oral en sobre

    The George Institute

    colorectal cancer early detection

    approved small molecule active

    1 trial

  7. Combination of antiplatelet drugs and anticoagulants for at least one month

    The First People's Hospital of Lianyungang

    Acute Myocardial Infarction

    approved small molecule active

    1 trial

  8. Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 0.2 mg/mL dispersion for injection COVID-19 mRNA Vaccine, EVUSHELD 150 mg + 150 mg solution for injection, Xevudy 500 mg concentrate for solution for infusion, Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)

    The George Institute

    Covid-19 infection

    approved small molecule active

    1 trial

  9. Commercial Hylenex® recombinant (hyaluronidase human injection)

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

  10. Conoxia® Vloeibaar, 100% v/v, medicinaal gas, cryogeen

    Disc Medicine

    Pulmonary Hypertension, Coronary Microvascular Dysfunction, Hypoxia, Heart Failure

    approved small molecule active

    1 trial

  11. DOBUTAMINE , LEVOSIMENDAN

    The George Institute

    Heart failure patients with depressed left ventricular ejection fraction

    approved small molecule active

    1 trial

  12. DOTAREM 0,5 mmol/ml oplossing voor injectie in injectieflacons.

    Disc Medicine

    Breast Cancer

    approved small molecule active

    1 trial

  13. Danhong injection

    BRIGHT MINDS BIOSCIENCES INC.

    Unstable Angina Pectoris

    approved small molecule completed

    1 trial

  14. Danhong injection

    BRIGHT MINDS BIOSCIENCES INC.

    Acute Stroke

    approved small molecule completed

    1 trial

  15. De-escalation strategy

    Dong Wang

    Acute Myocardial Infarction

    approved small molecule active

    1 trial

  16. Dexamethasone 4 mg tablets, Dexamethasone Phosphate 4 mg/ml Solution for Injection

    Disc Medicine

    Solid tumors

    approved small molecule active

    1 trial

  17. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Renal Function

    approved small molecule active

    1 trial

  18. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Obstructive Sleep Apnea

    approved small molecule completed

    1 trial

  19. Dexmedetomidine-esketamine combination

    The First People's Hospital of Lianyungang

    Obstructive Sleep Apnea

    approved small molecule active

    1 trial

  20. Dupilumab

    Regeneron UK Limited

    Dermal Hypersensitivity Reaction

    approved small molecule completed

    1 trial

  21. Dupilumab

    Regeneron UK Limited

    Chronic Obstructive Pulmonary Disease

    approved small molecule active

    1 trial

  22. Dupilumab, dupilumab placebo, solution for injection in pre-filled syringe

    Sanofi-aventis Healthcare Pty Ltd

    Asthma

    approved small molecule active

    1 trial

  23. Dysport 300 E, poeder voor oplossing voor injectie

    Disc Medicine

    Dystonic tremor syndrome

    approved small molecule active

    1 trial

  24. EV71 inactived vaccine（Vero cells）

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources